OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Aug 11, 2026, 4:00 PM EDT
1.600
+0.080 (5.26%)
After-hours: Aug 11, 2026, 4:22 PM EDT
OKYO Pharma Employees
OKYO Pharma had 5 employees as of March 31, 2026. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,789,931
Market Cap
79.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | 1 | 25.00% |
| Mar 31, 2025 | 4 | 1 | 33.33% |
| Mar 31, 2024 | 3 | -5 | -62.50% |
| Mar 31, 2023 | 8 | 1 | 14.29% |
| Mar 31, 2022 | 7 | 1 | 16.67% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Verrica Pharmaceuticals | 76 |
| NeurAxis | 24 |
| MAIA Biotechnology | 13 |
| Atara Biotherapeutics | 13 |
| Alterity Therapeutics | 9 |
OKYO News
- 14 days ago - Okyo Pharma CSO Raj Patil purchases 3,363 shares at $1.49 - TheFly
- 14 days ago - OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer - GlobeNewsWire
- 15 days ago - OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026 - GlobeNewsWire
- 19 days ago - Okyo Pharma director John Brancaccio acquires 5,000 shares at $1.38 - TheFly
- 19 days ago - OKYO Pharma Announces Purchase of Shares by Director - GlobeNewsWire
- 19 days ago - Okyo Pharma CEO Robert Dempsey purchases 15,000 shares at $1.54 - TheFly
- 19 days ago - OKYO Pharma Announces Purchase of Shares by Chief Executive Officer - GlobeNewsWire
- 20 days ago - Okyo Pharma says Chairman Gabriele Cerrone buys 22,500 shares at $1.45/share - TheFly